New drug duo shows promise for tough-to-treat lung cancer
NCT ID NCT03672773
First seen Nov 10, 2025 · Last updated May 14, 2026 · Updated 33 times
Summary
This study tests whether a combination of two drugs, talazoparib and temozolomide, can shrink tumors in people with advanced small cell lung cancer that has come back after initial treatment. The trial includes 35 adults whose cancer has progressed within 6 months of first-line chemotherapy. The goal is to see if the drugs work better together than either alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT EXTENSIVE STAGE SMALL CELL LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center
Bakersfield, California, 93309, United States
-
Cancer Center of Kansas
Wichita, Kansas, 67214, United States
-
Ft. Wayne Medical Oncology and Hematology, Inc.
Fort Wayne, Indiana, 46804, United States
-
Orlando Health, Inc. d/b/a Orlando Health UF Health Center
Orlando, Florida, 32806, United States
-
St. Joseph Heritage Healthcare
Fullerton, California, 92835, United States
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.